PRESS RELEASE published on 04/29/2026 at 07:05, 4 months 23 days ago Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026 Heidelberg Pharma AG reports significant progress in the first quarter of 2026 financially and in clinical development, completion of Phase I clinical trial, milestone payments triggered, and extended cash reach Clinical Development Phase I Trial Heidelberg Pharma AG Milestone Payments Financial Progress
BRIEF published on 04/17/2026 at 09:43, 5 months 5 days ago Heidelberg Pharma Announces Executive Board Change CFO Appointment Biotech Clinical Trial Heidelberg Pharma Executive Change
BRIEF published on 04/17/2026 at 09:43, 5 months 5 days ago Heidelberg Pharma annonce un changement au sein de son conseil d'administration. Biotechnologie Essai Clinique Nomination Du Directeur Financier Heidelberg Pharma Changement Exécutif
PRESS RELEASE published on 04/17/2026 at 09:38, 5 months 5 days ago Heidelberg Pharma Announces Change in Executive Board Heidelberg Pharma announces change in Executive Board as CFO Walter Miller departs end of April, Peter Willinger appointed as new CFO from 1 May 2026. Company specializes in developing Antibody Drug Conjugates (ADCs) CFO Executive Board Heidelberg Pharma Antibody Drug Conjugates ADCs
BRIEF published on 04/09/2026 at 14:31, 5 months 12 days ago Heidelberg Pharma fait progresser son candidat ADC HDP-101 vers la phase II des essais cliniques. Heidelberg Pharma Essai De Phase II Recherche Clinique Myélome Multiple ADC HDP-101
BRIEF published on 04/09/2026 at 14:31, 5 months 12 days ago Heidelberg Pharma Advances ADC Candidate HDP-101 to Phase II Trial Clinical Research Heidelberg Pharma Phase II Trial Multiple Myeloma ADC HDP-101
PRESS RELEASE published on 04/09/2026 at 14:26, 5 months 12 days ago EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101 Heidelberg Pharma AG determines recommended Phase II dose for ADC candidate HDP-101 in multiple myeloma trial, plans Phase IIa initiation shortly Heidelberg Pharma AG Multiple Myeloma ADC Candidate Phase II Dose Phase IIa Trial
BRIEF published on 04/04/2026 at 10:12, 5 months 18 days ago Heidelberg Pharma to Showcase ADC Technology at AACR 2026 Heidelberg Pharma ADC Technology Prostate Cancer AACR 2026 HDP-103
BRIEF published on 04/04/2026 at 10:12, 5 months 18 days ago Heidelberg Pharma présentera sa technologie ADC lors du congrès AACR 2026 Heidelberg Pharma Cancer De La Prostate Technologie ADC AACR 2026 HDP-103
PRESS RELEASE published on 04/04/2026 at 10:07, 5 months 18 days ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026 Heidelberg Pharma to present promising preclinical data of Amanitin-based ADC HDP-103 targeting mCRPC at AACR Annual Meeting 2026 in San Diego Heidelberg Pharma Amanitin-based ADC ADC Technology Platform AACR Annual Meeting 2026 MCRPC
Published on 09/22/2026 at 08:00, 2 hours 28 minutes ago Coretura Selects Alloy Kore to Advance a Unique Software-Defined Vehicle Platform for Its Commercial Vehicle Customers
Published on 09/22/2026 at 08:00, 2 hours 28 minutes ago Caledonia Mining Corporation PLC: Notification of Relevant Change to Significant Shareholder
Published on 09/22/2026 at 06:45, 3 hours 43 minutes ago Akkodis and Hamburg Public Transport Association Showcase hvv mia at InnoTrans 2026, Demonstrating the Future of AI-Powered Mobility
Published on 09/22/2026 at 06:45, 3 hours 43 minutes ago Akkodis et l’association des transports publics de Hambourg présentent hvv mia à InnoTrans 2026 et montrent comment l’IA transforme la mobilité.
Published on 09/22/2026 at 06:45, 3 hours 43 minutes ago Akkodis en Hamburger Verkehrsverbund presenteren hvv mia op InnoTrans 2026 en tonen de toekomst van AI-gedreven mobiliteit
Published on 09/22/2026 at 10:05, 23 minutes ago Hedia Secures Regulatory Approval to Expand Digital Diabetes Care to Pediatric Patients
Published on 09/22/2026 at 09:55, 33 minutes ago Original-Research: HORNBACH Holding AG & Co. KGaA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 09/22/2026 at 09:30, 58 minutes ago Invitation to the 20th International Investment Forum (IIF) on October 7, 2026 – International investment opportunities in direct dialogue
Published on 09/22/2026 at 09:25, 1 hour 3 minutes ago EYKON Strengthens Strategic Focus Through Sale of Water Meter Business to Sensus International
Published on 09/21/2026 at 18:19, 16 hours 9 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 16 hours 9 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 16 hours 27 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 16 hours 42 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 16 hours 42 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
